Otros idiomas Alpha Cognition Inc.

Acciones

ACOG

CA02074J2048

Diferido Canadian Securities Exchange Otros sitios de cotización 15:33:32 08/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,68 ^CAD	0,00 %		+1,49 %	+3,03 %

04/04	La pérdida global del cuarto trimestre de Alpha Cognition se amplía un poco respecto al periodo anterior	MT
04/04	Alpha Cognition Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period	04/04
Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/04
Alpha Cognition to Present at the Life Science Investor Forum March 7th	01/03
Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease	22/02
Alpha Cognition Inc. Files Composition-Of-M Matter Patent	22/02
Alpha Cognition Provides Business Update	12/02
Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment	19/01
Alpha Cognition Inc. announced that it has received $8.45 million in funding	19/01
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering	22/12
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's disease	08/12
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease	07/12
Alpha Cognition Inc. Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-To-Moderate Alzheimer's Disease	07/12
Alpha Cognition Reports Amended Terms of Private Placement, Continuation of the Offering	05/12
Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering	05/12
Alpha Cognition Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
Alpha Cognition Announces Third Closing of Private Placement and Continuation of the Offering	08/11
Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering	16/10/23
Canadian Investment Regulatory Organization Trading Halt - ACOG.WT	02/10/23
Alpha Cognition Inc. Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer?s Disease	27/09/23
Alpha Cognition Announces Initial Closing of Private Placement and Pricing for Continuation of the Offering	01/09/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Alpha Cognition Inc.

Acciones

ACOG

CA02074J2048

Otros idiomas

Filtros